A clinical trial conducted jointly by the Research Institute of Hospital del Mar and the Barcelonaβeta Brain Research Center, concludes that combining a healthy lifestyle program with epigallocatechin gallate (EGCG), a natural compound found in green tea, could offer sustained cognitive benefits in people at high risk of developing Alzheimer’s dise
The drug was approved following a review of new data submitted by the pharmaceutical company after an initial negative opinion in March of this year.
This research achieved a more precise measurement of sleep quality thanks to the combined use of actigraphy, brain MRI scans, and biomarker analysis.
Her work focused on understanding how telomere length—a key marker of biological aging—influences brain vulnerability and the development of Alzheimer’s disease.
Our researchers will present 7 talks and 22 scientific posters during the 5 days of the congress
The international consortium has analyzed almost 40,000 biological samples to identify biomarkers in Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative diseases.
This study suggests that certain stressful life events can impact brain health differently depending on gender and educational level
The project will last two years and aims to uncover why Alzheimer’s disease affects people in different ways and how its course can be more accurately predicted.
This interdisciplinary initiative is designed to provide healthcare providers with a set of innovative tools to improve disease identification and management.